$FEAM
5E Advanced Materials, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024126394 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.798M
YoY Change -20.54%
% of Gross Profit
Research & Development $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit
Depreciation & Amortization $5.000M $4.972M
YoY Change 10316.67% 9281.13%
% of Gross Profit
Operating Expenses $11.03M $12.91M
YoY Change 24.14% 67.39%
Operating Profit -$11.03M -$12.91M
YoY Change 24.14% 67.39%
Interest Expense $2.430M $2.155M
YoY Change 39.74% 20.59%
% of Operating Profit
Other Income/Expense, Net -$3.231M $52.00K
YoY Change 86.76% -103.14%
Pretax Income -$14.26M -$12.86M
YoY Change 34.34% 37.24%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$14.26M -$12.86M
YoY Change 34.34% 37.24%
Net Earnings / Revenue
Basic Earnings Per Share -$0.21 -$0.20
Diluted Earnings Per Share -$0.21 -$0.20
COMMON SHARES
Basic Shares Outstanding 68.88M 68.83M
Diluted Shares Outstanding 68.89M 65.47M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.851M
YoY Change -41.92%
Cash & Equivalents $824.0K $6.851M
Short-Term Investments
Other Short-Term Assets $1.258M
YoY Change -1.18%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.451M $8.109M
YoY Change -58.39% -37.95%
LONG-TERM ASSETS
Property, Plant & Equipment $63.64M $68.62M
YoY Change 2012.78% 2141.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $317.0K
YoY Change 0.96%
Total Long-Term Assets $73.38M $77.67M
YoY Change -12.28% -6.06%
TOTAL ASSETS
Total Short-Term Assets $1.451M $8.109M
Total Long-Term Assets $73.38M $77.67M
Total Assets $74.83M $85.77M
YoY Change -14.12% -10.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.481M
YoY Change -25.09%
Accrued Expenses $5.988M
YoY Change -16.9%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $43.00K $42.00K
YoY Change 4.88% 2.44%
Total Short-Term Liabilities $9.425M $7.511M
YoY Change 5.22% -18.57%
LONG-TERM LIABILITIES
Long-Term Debt $81.11M $81.12M
YoY Change 27.43% 27.43%
Other Long-Term Liabilities $3.738M
YoY Change 373.76%
Total Long-Term Liabilities $81.11M $81.12M
YoY Change 27.43% 27.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.425M $7.511M
Total Long-Term Liabilities $81.11M $81.12M
Total Liabilities $83.23M $83.68M
YoY Change 59.6% 64.16%
SHAREHOLDERS EQUITY
Retained Earnings -$227.1M -$212.9M
YoY Change 43.77% 44.45%
Common Stock $689.0K $689.0K
YoY Change 55.88% 55.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.397M $2.094M
YoY Change
Total Liabilities & Shareholders Equity $74.83M $85.77M
YoY Change -14.12% -10.41%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$14.26M -$12.86M
YoY Change 34.34% 37.24%
Depreciation, Depletion And Amortization $5.000M $4.972M
YoY Change 10316.67% 9281.13%
Cash From Operating Activities -$6.375M
YoY Change -7.42%
INVESTING ACTIVITIES
Capital Expenditures $11.00K
YoY Change -78.43%
Acquisitions
YoY Change
Other Investing Activities $86.00K
YoY Change
Cash From Investing Activities -$400.0K
YoY Change -75.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.730M
YoY Change -87400.0%
NET CHANGE
Cash From Operating Activities -6.375M
Cash From Investing Activities -400.0K
Cash From Financing Activities 8.730M
Net Change In Cash 1.955M
YoY Change -122.93%
FREE CASH FLOW
Cash From Operating Activities -$6.375M
Capital Expenditures $11.00K
Free Cash Flow -$6.386M
YoY Change -7.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 dei Amendment Flag
AmendmentFlag
false
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001888654
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity File Number
EntityFileNumber
001-41279
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
5E ADVANCED MATERIALS, INC.
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3426517
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
9329 Mariposa Road
CY2024Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Hesperia
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92344
CY2024Q3 dei City Area Code
CityAreaCode
442
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
221-0225
CY2024Q3 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2024Q3 dei Trading Symbol
TradingSymbol
FEAM
CY2024Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q3 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68883030
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6851000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4896000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1258000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1913000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
8109000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
6809000
CY2024Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
7633000
CY2024Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
7616000
CY2024Q3 feam Construction In Progress
ConstructionInProgress
849000
CY2024Q2 feam Construction In Progress
ConstructionInProgress
608000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
68623000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
73872000
CY2024Q3 feam Reclamation Bond Deposit
ReclamationBondDeposit
311000
CY2024Q2 feam Reclamation Bond Deposit
ReclamationBondDeposit
311000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
243000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
282000
CY2024Q3 us-gaap Other Assets
OtherAssets
6000
CY2024Q2 us-gaap Other Assets
OtherAssets
6000
CY2024Q3 us-gaap Assets
Assets
85774000
CY2024Q2 us-gaap Assets
Assets
89504000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7390000
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9567000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
121000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
141000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7511000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9708000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
72431000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
64831000
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2771000
CY2024Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3315000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
130000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
149000
CY2024Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
837000
CY2024Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
795000
CY2024Q3 us-gaap Liabilities
Liabilities
83680000
CY2024Q2 us-gaap Liabilities
Liabilities
78798000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
360000000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
360000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68883000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63318000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
689000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
633000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
214265000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
210074000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-212860000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-200001000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2094000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
10706000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
85774000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89504000
CY2024Q3 feam Project Expenses
ProjectExpenses
1554000
CY2023Q3 feam Project Expenses
ProjectExpenses
1583000
CY2024Q3 feam Small Scale Facility Operating Costs
SmallScaleFacilityOperatingCosts
1587000
CY2023Q3 feam Small Scale Facility Operating Costs
SmallScaleFacilityOperatingCosts
0
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4798000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6038000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4972000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
12911000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7713000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12911000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7713000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
23000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
132000
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1000
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3000
CY2024Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2187000
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2155000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1787000
CY2024Q3 feam Other Non Operating Income Expense Excluding Other Income
OtherNonOperatingIncomeExpenseExcludingOtherIncome
-4000
CY2023Q3 feam Other Non Operating Income Expense Excluding Other Income
OtherNonOperatingIncomeExpenseExcludingOtherIncome
-5000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
52000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1657000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12859000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9370000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-12859000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9370000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65468000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65468000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44221000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44221000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-12859000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9370000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4972000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
53000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1350000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
599000
CY2024Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2187000
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0
CY2024Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
19000
CY2023Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
17000
CY2024Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
324000
CY2023Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1452000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
39000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
40000
CY2024Q3 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-655000
CY2023Q3 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-535000
CY2024Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1312000
CY2023Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-212000
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6375000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6886000
CY2024Q3 feam Payments For Construction In Progress
PaymentsForConstructionInProgress
475000
CY2023Q3 feam Payments For Construction In Progress
PaymentsForConstructionInProgress
1580000
CY2024Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11000
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
51000
CY2024Q3 feam Refund On Previously Acquired Equipment
RefundOnPreviouslyAcquiredEquipment
86000
CY2023Q3 feam Refund On Previously Acquired Equipment
RefundOnPreviouslyAcquiredEquipment
0
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-400000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1631000
CY2024Q3 feam Proceeds From Issuance Of Common Stock And Warrants Net Of Offering Costs
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfOfferingCosts
3144000
CY2023Q3 feam Proceeds From Issuance Of Common Stock And Warrants Net Of Offering Costs
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfOfferingCosts
0
CY2024Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6000000
CY2023Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2024Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
282000
CY2023Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2024Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10000
CY2023Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10000
CY2024Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
122000
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8730000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1955000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8527000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4896000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20323000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6851000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11796000
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
18000
CY2024Q3 feam Accounts Payable And Accrued Liabilities Change Related To Capital Additions
AccountsPayableAndAccruedLiabilitiesChangeRelatedToCapitalAdditions
-442000
CY2023Q3 feam Accounts Payable And Accrued Liabilities Change Related To Capital Additions
AccountsPayableAndAccruedLiabilitiesChangeRelatedToCapitalAdditions
2364000
CY2024Q3 feam Accounts Payable And Accrued Liabilities Change Related To Equity Issuance Costs
AccountsPayableAndAccruedLiabilitiesChangeRelatedToEquityIssuanceCosts
121000
CY2023Q3 feam Accounts Payable And Accrued Liabilities Change Related To Equity Issuance Costs
AccountsPayableAndAccruedLiabilitiesChangeRelatedToEquityIssuanceCosts
0
CY2024Q3 feam Accounts Payable And Accrued Liabilities Change Related To Debt Issuance Costs
AccountsPayableAndAccruedLiabilitiesChangeRelatedToDebtIssuanceCosts
-85000
CY2023Q3 feam Accounts Payable And Accrued Liabilities Change Related To Debt Issuance Costs
AccountsPayableAndAccruedLiabilitiesChangeRelatedToDebtIssuanceCosts
0
CY2024Q3 feam Interest Paid Through Issuance Of Additional Convertible Notes
InterestPaidThroughIssuanceOfAdditionalConvertibleNotes
3126000
CY2023Q3 feam Interest Paid Through Issuance Of Additional Convertible Notes
InterestPaidThroughIssuanceOfAdditionalConvertibleNotes
1851000
CY2024Q3 feam Increase Decrease In Asset Retirement Costs
IncreaseDecreaseInAssetRetirementCosts
23000
CY2023Q3 feam Increase Decrease In Asset Retirement Costs
IncreaseDecreaseInAssetRetirementCosts
0
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
53566000
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-31000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
599000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9370000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
44764000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
10706000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1522000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1502000
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-127000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1350000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-12859000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2094000
CY2024Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concentrations of Risk</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company maintains cash deposits at several major banks, which at times may exceed amounts covered by insurance provided by the United States Federal Deposit Insurance Corporation. Management monitors the financial health of the banks and believes the Company is not exposed to any significant credit risk, and the Company has not experienced any such losses.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s operations are predominately focused on the Project, which results in the Company being dependent upon a single mining operation in a single geographic region in the western United States in California. The geographic concentration of the Company’s operations may disproportionately expose it to disruptions if the region experiences severe weather, transportation capacity constraints, constraints on the availability of required equipment, facilities, personnel or services, significant governmental regulation or natural disasters.</span></p>
CY2024Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to prior years’ reported amounts in order to conform to the current year presentation. These reclassifications did not impact our previously reported net income (loss), stockholders’ equity or cash flows.</span></p>
CY2024Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
7633000
CY2024Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
7616000
CY2024Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
849000
CY2024Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
608000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
79057000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
79339000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10434000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5467000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
68623000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
73872000
CY2024Q3 us-gaap Depreciation
Depreciation
5000000
CY2023Q3 us-gaap Depreciation
Depreciation
47000
CY2024Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
795000
CY2024Q3 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
23000
CY2024Q3 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0
CY2024Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
19000
CY2024Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
837000
CY2024Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1481000
CY2024Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
854000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1258000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
603000
CY2024Q3 feam Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
2944000
CY2024Q2 feam Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
3309000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
702000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2263000
CY2024Q3 feam Accrued Interest Current
AccruedInterestCurrent
963000
CY2024Q2 feam Accrued Interest Current
AccruedInterestCurrent
2496000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
42000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
42000
CY2024Q3 feam Accounts Payable And Accrued Liabilities Including Current Portion Of Long Term Debt
AccountsPayableAndAccruedLiabilitiesIncludingCurrentPortionOfLongTermDebt
7390000
CY2024Q2 feam Accounts Payable And Accrued Liabilities Including Current Portion Of Long Term Debt
AccountsPayableAndAccruedLiabilitiesIncludingCurrentPortionOfLongTermDebt
9567000
CY2024Q3 feam Capital Expenditure Included In Trade Accounts Payable
CapitalExpenditureIncludedInTradeAccountsPayable
129000
CY2024Q2 feam Capital Expenditure Included In Trade Accounts Payable
CapitalExpenditureIncludedInTradeAccountsPayable
235000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
81161000
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
71779000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
42000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
42000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
81119000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
71737000
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5525000
CY2024Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4035000
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3163000
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2871000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
72431000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
64831000
CY2024Q3 feam Convertible Note Interest
ConvertibleNoteInterest
1859000
CY2023Q3 feam Convertible Note Interest
ConvertibleNoteInterest
940000
CY2024Q3 feam Vehicle Notes Payable Interest
VehicleNotesPayableInterest
1000
CY2023Q3 feam Vehicle Notes Payable Interest
VehicleNotesPayableInterest
1000
CY2024Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
324000
CY2023Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1452000
CY2024Q3 us-gaap Interest Expense Other
InterestExpenseOther
0
CY2023Q3 us-gaap Interest Expense Other
InterestExpenseOther
18000
CY2024Q3 feam Gross Interest Expense
GrossInterestExpense
2184000
CY2023Q3 feam Gross Interest Expense
GrossInterestExpense
2411000
CY2024Q3 feam Amount Capitalized To Construction In Progress
AmountCapitalizedToConstructionInProgress
29000
CY2023Q3 feam Amount Capitalized To Construction In Progress
AmountCapitalizedToConstructionInProgress
624000
CY2024Q3 us-gaap Interest Expense
InterestExpense
2155000
CY2023Q3 us-gaap Interest Expense
InterestExpense
1787000
CY2024Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.127
CY2023Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.232
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
81063000
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8688000
CY2024Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
72375000
CY2024Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
53560000
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
71671000
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
6906000
CY2024Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
64765000
CY2024Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
65231000
CY2024Q2 feam Convertible Note Derivative Liability
ConvertibleNoteDerivativeLiability
3315000
CY2024Q3 feam Convertible Note Derivative Additions
ConvertibleNoteDerivativeAdditions
1643000
CY2024Q3 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
2187000
CY2024Q3 feam Convertible Note Derivative Liability
ConvertibleNoteDerivativeLiability
2771000
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
360000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5333333
CY2024Q3 feam Combined Price Of Shares And Warrants Value Per Share
CombinedPriceOfSharesAndWarrantsValuePerShare
0.75
CY2024Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4001000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.33
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4187000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.91
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
301000
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.27
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
300000
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.73
CY2024Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q3 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriod
1660000
CY2024Q3 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriodWeightedAverageExercisePrice
5.26
CY2023Q3 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriod
278000
CY2023Q3 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriodWeightedAverageExercisePrice
25.49
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2642000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.97
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4209000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.71
CY2024Q3 feam Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriod
2000000
CY2024Q3 feam Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
13.58
CY2023Q3 feam Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriod
3356000
CY2023Q3 feam Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
9.83
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
642000
CY2024Q3 feam Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice
2.85
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
853000
CY2023Q3 feam Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice
9.25
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
341000
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.79
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
838000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.42
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
301000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.22
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
300000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.08
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
7000
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6.85
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
278000
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
10.48
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
642000
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.05
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
853000
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.57
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2024Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
2184000
CY2023Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
2393000
CY2024Q3 feam Derivative Gain Loss On Convertible Notes Derivatives
DerivativeGainLossOnConvertibleNotesDerivatives
2187000
CY2023Q3 feam Derivative Gain Loss On Convertible Notes Derivatives
DerivativeGainLossOnConvertibleNotesDerivatives
0
CY2024Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
55480000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
3611000
CY2024Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
10667000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3566000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4780000
CY2024Q3 us-gaap Purchase Obligation
PurchaseObligation
4300000
CY2023Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
5500000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-126394-index-headers.html Edgar Link pending
0000950170-24-126394-index.html Edgar Link pending
0000950170-24-126394.txt Edgar Link pending
0000950170-24-126394-xbrl.zip Edgar Link pending
feam-20240930.htm Edgar Link pending
feam-20240930.xsd Edgar Link pending
feam-ex31_1.htm Edgar Link pending
feam-ex31_2.htm Edgar Link pending
feam-ex32_1.htm Edgar Link pending
feam-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img212525448_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
feam-20240930_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable